데이터가 없습니다.

1. Clinical features and oncological outcomes of primary female urethral cancer [ JOURNAL OF SURGICAL ONCOLOGY ] - 2022.04.01
2. Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy? [ Taiwanese Journal of Obstetrics & Gynecology ] - 2022.03.30
3. Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial [ TRIALS ] - 2021.10.21
4. Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trial [ BMC CANCER ] - 2021.09.16
5. Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis [ CANCERS ] - 2021.08.01
6. Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15) [ Cancers ] - 2021.06.10
7. Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03) [ EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY ] - 2021.03.15
8. Impact of intracavitary brachytherapy technique (2D versus 3D) on outcomes of cervical cancer: a systematic review andmeta-analysis [ STRAHLENTHERAPIE UND ONKOLOGIE ] - 2020.11.01
9. Phase I/IIa Trial of Androgen Deprivation Therapy, External Beam Radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR) [ Radiation Oncology ] - 2020.10.10
10. Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer [ JAPANESE JOURNAL OF CLINICAL ONCOLOGY ] - 2020.10.05
11. Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study [ SCIENTIFIC REPORTS ] - 2020.09.08
12. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy [ GYNECOLOGIC ONCOLOGY ] - 2020.05.15
13. Prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis [ Journal of Gynecologic Oncology ] - 2019.09.01
14. Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis [ PLoS One ] - 2019.04.11
15. Patterns of Recurrence After Salvage Radiotherapy Encompassing Pelvic Lymphatics in Men with High-risk Prostate Cancer [ ANTICANCER RESEARCH ] - 2018.11.06
16. Prognostic significance of lymph node ratio in node-positive cervical cancer patients [ MEDICINE ] - 2018.07.15
17. Stereotactic body-radiotherapy boost dose of 18 Gy vs. 21 Gy in combination with androgen-deprivation therapy and whole pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial [ Trials ] - 2018.04.02
18. Risk prediction model for disease-free survival in women with early stage cervical cancers following postoperative (chemo)radiotherapy [ TUMORI ] - 2018.03.01
19. Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients [ PLOS ONE ] - 2018.01.10
20. Oncologic outcomes after adjuvant radiotherapy for stage II endometrial cancer [ INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER ] - 2017.09.01
21. Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis [ ONCOTARGET ] - 2017.03.25
22. Variability in target delineation of cervical carcinoma: a Korean radiation oncology group study (KROG 15-06) [ PLoS One ] - 2017.03.16
23. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer [ GYNECOLOGIC ONCOLOGY ] - 2017.01.01
24. Analysis of prostate bed motion using an endorectal balloon and cone beam computed tomography during postprostatectomy radiotherapy [ OncoTargets and Therapy ] - 2016.05.24
25. A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer [ OncoTargets and Therapy ] - 2016.03.09
26. Definitive extended-field intensity-modulated radiotherapy with chemotherapy for cervical cancer with para-aortic nodal metastasis [ ANTICANCER RESEARCH ] - 2014.08.01
27. A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: A Korean radiation oncology group study (KROG 12-08) [ RADIOTHERAPY AND ONCOLOGY ] - 2014.06.05
28. Incidence and dose-volume analysis of acute bladder toxicity following pelvic radiotherapy [ TUMORI ] - 2014.03.01
29. Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract [ ANTICANCER RESEARCH ] - 2014.01.01
30. Whole pelvic intensity-odulated radiotherapy for high-risk prostate cancer: a preliminary report [ 대한방사선종양학회지 ] - 2013.12.30
31. Individualized prediction of overall survival after postoperative radiation therapy in patients with early stage cervical cancer: a Korean Radiation Oncology Group Study (KROG 13-03) [ INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ] - 2013.11.15
32. Low production of reactive oxygen species and high DNA repair: mechanism of radioresistance of prostate cancer stem cells. [ ANTICANCER RESEARCH ] - 2013.10.01
33. Additional value of combined evaluation of tumor size with lymph node size in the dectection of lymph node metastases in early-stage carvical cancer patients [ JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY ] - 2013.07.30
34. Curative chemoradiotherapy in patients With stage IVB cervical cancer presenting with paraaortic and left supraclavicular lymph node metastases [ INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ] - 2012.11.01
35. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer [ TUMORI ] - 2012.09.01
36. low-dose external beam radiotherpay as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee [ ACTA ORTHOPAEDICA ] - 2012.06.01
37. Inter- and intra-observer variability in contouring of the prostate gland on planning computed tomography and cone beam computed tomography [ ACTA ONCOLOGICA ] - 2011.05.01
38. Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women [ TUMORI ] - 2010.12.31
39. Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery [ TUMORI ] - 2010.09.20

1. 부인암환자에서 환자 혈액 관리 프로그램의 안정성과 유효성을 평가하기 위한 전향적 무작위 배정 연구 - 2024.01.01 ~ 2024.12.31
2. 부인암환자에서 환자 혈액 관리 프로그램의 안정성과 유효성을 평가하기 위한 전향적 무작위 배정 연구 - 2023.01.01 ~ 2023.12.31
3. 부인암환자에서 환자 혈액 관리 프로그램의 안정성과 유효성을 평가하기 위한 전향적 무작위 배정 연구 - 2022.07.01 ~ 2022.12.31
4. 전립선암 생화학적 재발에 대한 구제 방사선치료 연구 - 2020.06.05 ~ 2027.02.28
5. 근육 침습성 방광암(Muscle-invasive Bladder Cancer, MIBC) 환자를 대상으로 화학방사선요법(Chemoradiotherapy, CRT)과의 병합요법으로 투여한 Pembrolizumab(MK-3475)의 유효성과 안전성을 CRT만 실시하는 것과 비교 평가하기 위한 제3상, 무작위배정, 이중눈가림, 위약 - 2020.01.21 ~ 2027.01.09
6. 방사선치료에 따른 정상조직의 독성 예방 및 완화 - 2019.06.01 ~ 2020.05.31
7. 골반부 방사선치료를 받는 환자들에게 프로바이오틱스 복용을 통한 급성 장독성 예방: 무작위 전향적, 2중 눈가림, 3상, 우월성 연구 - 2019.05.29 ~ 2021.06.30
8. 중등도 및 고위험군 전립선암으로 근치적 전립선적출술을 받은 후 생화학적 재발 환자들에게 저분할 고선량 및 표준 구제방사선치료의 비교: 무작위 전향적, 3상 우월성 연구 - 2019.03.11 ~ 2027.02.28
9. 빌리루빈 나노물질을 이용한 방사선치료 후 정상조직의 만성독성 예방 - 2019.03.01 ~ 2019.05.31
10. 단백체 및 전사체 통합 분석을 통한 기전 연구 platform 구축 - 2019.01.01 ~ 2019.12.31
11. 빌리루빈 나노물질을 이용한 방사선치료 후 정상조직의 만성독성 예방 - 2018.04.01 ~ 2019.02.28
12. 빌리루빈 나노물질을 이용한 방사선치료 후 정상조직의 만성독성 예방 - 2017.06.01 ~ 2018.03.31
13. 빌리루빈 나노물질을 이용한 방사선치료 후 정상조직의 만성독성 예방 - 2016.06.01 ~ 2017.05.31
14. 중등도 및 고위험군 전립선암에서 호르몬차단, 외부방사선치료, 정위적방사선수술의 병합요법 - 2016.03.21 ~ 2017.02.28
15. 방사선치료, 종양파괴 바이러스, 지방줄기세포를 이용한 암 치료 향상(2) - 2013.09.01 ~ 2014.08.31
16. 방사선치료를 받은 환자들에게서 혈중 citrulline을 이용한 소장 독성의 평가 - 2013.02.22 ~ 2014.03.31
17. 방사선치료를 받은 환자들에게서 혈중 citrulline을 이용한 소장 독성의 평가 - 2013.02.22 ~ 2014.03.31
18. 방사선치료, 종양파괴 바이러스, 지방줄기세포를 이용한 암 치료 향상(1) - 2012.09.01 ~ 2013.08.31
19. 리오바이러스와 방사선치료의 병합을 통한 위암 치료효과의 증진[2] - 2011.04.01 ~ 2012.03.31
20. 리오바이러스와 방사선치료의 병합을 통한 위암 치료효과의 증진 - 2010.05.01 ~ 2011.03.31

데이터가 없습니다.

      데이터가 없습니다.

 공지